Viewing Study NCT05603195


Ignite Creation Date: 2025-12-24 @ 2:14 PM
Ignite Modification Date: 2026-02-26 @ 1:52 AM
Study NCT ID: NCT05603195
Status: COMPLETED
Last Update Posted: 2024-10-01
First Post: 2022-10-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Trial to Learn if Single Ascending Intravenous (IV) Doses of REGN7508 Are Safe and Well Tolerated, and How it Works in the Body of Healthy Adult Participants
Sponsor: Regeneron Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module